Cellenion

Cellenion offers solutions and technologies for controlled cell dispensing with applications in the fields of single-cell isolation and bioprinting : Ability to manipulate single-cell has long been a challenge for the scientific community due to their micrometric size and delicate nature. Cellenion has developed and patented CellenONE, a breakthrough single cell isolation and dispensing technology. CellenONE provides outstanding single cell precision, high throughput, and unmatched recovery. Bioprinting is the process of generating spatially-controlled cell patterns using 3D printing technologies. Cellenion will aim toward both miniaturization and automation in order to produce reproducible models of different complexities

Single cell isolation & dispensing,bioprinting,single cell analysis,controlled cell dispensing,cloning,and single cell

Cellenion operates in the Biotechnology industry.

Cellenion's revenue is 11m - 100m

Cellenion has 11 - 50 employees.